Though previous research on the matter has shown that the use of statins may help protect against Parkinson’s, Penn State researchers say that those results have been inconsistent. In the new study, researchers used insurance data to compare over 2000 patients with Parkinson’s to a control group of people who did not have the disease and found that those who took statins had a higher risk of developing Parkinson’s.
“Statin use was associated with higher, not lower, Parkinson’s disease risk, and the association was more noticeable for lipophilic statins, an observation inconsistent with the current hypothesis that these statins protect nerve cells,” said Xumei Huang, MD, a professor of neurology.
More Articles on Clinical Quality:
100 patient safety benchmarks | 2017
Tamiflu no longer a ‘core’ drug, per WHO update
Pediatric chemotherapy linked to cognitive issues later in life
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.